These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29342193)

  • 1. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
    Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
    PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
    Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
    Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
    Lee CH; Alpert BO; Sankaranarayanan P; Alter O
    PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
    Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J
    Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
    Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
    Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
    Hodgson JG; Yeh RF; Ray A; Wang NJ; Smirnov I; Yu M; Hariono S; Silber J; Feiler HS; Gray JW; Spellman PT; Vandenberg SR; Berger MS; James CD
    Neuro Oncol; 2009 Oct; 11(5):477-87. PubMed ID: 19139420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number profiling across glioblastoma populations has implications for clinical trial design.
    Cimino PJ; McFerrin L; Wirsching HG; Arora S; Bolouri H; Rabadan R; Weller M; Holland EC
    Neuro Oncol; 2018 Sep; 20(10):1368-1373. PubMed ID: 29982740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic risk score for glioblastoma multiforme based on copy number variations.
    Ko C; Brody JP
    Cancer Treat Res Commun; 2021; 27():100352. PubMed ID: 33756171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
    Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
    Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathologic diagnosis of epidermal growth factor receptor.
    Maire CL; Ligon KL
    Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii1-6. PubMed ID: 25342599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
    Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
    Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
    Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
    Khatri RG; Navaratne K; Weil RJ
    J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
    Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
    Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.
    Aiello KA; Alter O
    PLoS One; 2016; 11(10):e0164546. PubMed ID: 27798635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
    Zheng S; Wu Y; Li Z
    Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.